A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study

Kimihiro Matsumoto, Nobuyuki Takayama, Yoshinobu Aisa, Hironori Ueno, Masao Hagihara, Kentaro Watanabe, Aya Nakaya, Kenko Chen, Takayuki Shimizu, Yuiko Tsukada, Yuji Yamada, Tomonori Nakazato, Akaru Ishida, Yoshitaka Miyakawa, Kenji Yokoyama, Hideaki Nakajima, Yoshihiro Masuda, Takahiro Yano, Shinichiro Okamoto

研究成果: Article査読

16 被引用数 (Scopus)

フィンガープリント

「A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

Medicine & Life Sciences